Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
H R Gralnick
H R Gralnick
Published August 1, 1978
Citation Information: J Clin Invest. 1978;62(2):496-499. https://doi.org/10.1172/JCI109152.
View: Text | PDF
Research Article

Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.

  • Text
  • PDF
Abstract

The normal Factor VIII/von Willebrand factor protein has the ability to agglutinate or aggregate normal platelets in the presence of ristocetin (von Willebrand factor activity). Removal of greater than 95% of the sialic acid from this protein by neuraminidase did not affect the von Willebrand factor or procoagulant activity. However, oxidation of the penultimate galactose of the asialo Factor VIII/von Willebrand factor protein with galactose oxidase resulted in a progressive loss of von Willebrand factor activity with no effect on procoagulant activity. Reduction of the 6-aldehydo intermediate by potassium borohydride caused full regeneration of von Willebrand factor activity. These studies confirm the identification of the intact penultimate galactose moiety as a critical determinant of von Willebrand factor activity.

Authors

H R Gralnick

×

Total citations by year

Year: 2021 2019 2011 2009 2006 2000 1990 1987 1986 1985 1984 1983 1982 1981 1980 1979 1968 1960 Total
Citations: 1 1 1 1 1 1 1 2 1 2 3 4 3 3 3 3 1 1 33
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (33)

Title and authors Publication Year
Desialylation of O‐glycans activates von Willebrand factor by destabilizing its autoinhibitory module
KM Voos, W Cao, NA Arce, ER Legan, Y Wang, A Shajahan, P Azadi, P Lollar, XF Zhang, R Li
Journal of Thrombosis and Haemostasis 2021
The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation
DE van der Wal, AM Davis, M Mach, DC Marks
Haematologica 2019
Production and Purification of Rabbit's Polyclonal Antibody Against Factor VIII
S Sohrabi, A Akbarzadeh, D Norouzian, A Farhangi, M Mortazavi, MR Mehrabi, M Chiani, Z Saffari, S Ghassemi
Indian Journal of Clinical Biochemistry 2011
Expression of terminal  2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13
RT McGrath, TA McKinnon, B Byrne, R O'Kennedy, V Terraube, E McRae, RJ Preston, MA Laffan, JS O'Donnell
Blood 2009
Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease
CM Millar, SA Brown
Blood Reviews 2006
Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor
R Sarode, J Goldstein, II Sussman, RL Nagel, HM Tsai
British Journal of Haematology 2000
Advances in Human Genetics
H Harris, K Hirschhorn
1990
Platelet Adhesion and Prevention at Blood-Polymer Interface
SW Kim
Artificial Organs 1987
von Willebrand disease
TS Zimmerman, ZM Ruggeri
Human Pathology 1987
The physiology and pathophysiology of the factor VIII complex
RJ Hamer, WP Houdijk, JJ Sixma, TW Barrowcliffe
Critical Reviews in Oncology/Hematology 1986
Platelet Membrane Glycoproteins
JN George, AT Nurden, DR Phillips
1985
Genetic Engineering and Coagulation Factors
DN Fass, JJ Toole
Clinics in Haematology 1985
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation
AB Federici, JH Elder, LD Marco, ZM Ruggeri, TS Zimmerman
Journal of Clinical Investigation 1984
The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII
PJ Fay, SI Chavin, JE Malone, D Schroeder, FE Young, VJ Marder
Biochimica et Biophysica Acta (BBA) - General Subjects 1984
Blood clotting factor IX. Loss of activity after cleavage of sialic acid residues
SI Chavin, SM Weidner
The Journal of biological chemistry 1984
ROLE OF VON WILLEBRAND FACTOR IN PLATELET ADHESION TO THE SUBENDOTHELIUM
D Meyer, HR Baumgartner
British Journal of Haematology 1983
Structure determination of the major asparagine-linked sugar chain of human factor VII—von Willebrand factor
P Debeire, J Montreuil, B Samor, C Mazurier, M Goudemand, HV Halbeek, JF Vliegenthart
FEBS Letters 1983
Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein
HR Gralnick, SB Williams, ME Rick
Proceedings of the National Academy of Sciences 1983
Von Willebrand's Disease
TS Zimmerman, ZM Ruggeri
Clinics in Haematology 1983
Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture
RL Nachman
The Western journal of medicine 1982
A fibronectin-binding glycoprotein from human platelet membranes
MS Hansen, I Clemmensen
Biochemical Journal 1982
Amino group modification inhibits ristocetin cofactor activity of human von Willebrand factor
SA Santoro
Biochemical and Biophysical Research Communications 1982
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent
LD Marco, SS Shapiro
Journal of Clinical Investigation 1981
Quantitation of Binding of Factor VIII Antigen to Concanavalin A
MA Howard, J Perkin, J Koutts, BG Firkin
British Journal of Haematology 1981
Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system
JM Hallenbeck, TW Furlow, HR Gralnick
Stroke; a journal of cerebral circulation 1981
Studies on factor VIII-related protein IV. Interaction of galactose-specific lectins with human factor VIII/von willebrand factor
M Furlan, BA Perret, EA Beck
Biochimica et Biophysica Acta (BBA) - Protein Structure 1980
von Willebrand's Disease: A Confusing Disorder
GR Buchanan
Pediatric Annals 1980
Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets
KJ Kao, SV Pizzo, PA McKee
The Journal of biological chemistry 1980
Carbohydrate of the Factor VIII/von Willebrand Factor in von Willebrand's Disease
TS Zimmerman, R Voss, TS Edgington
Journal of Clinical Investigation 1979
Studies on factor VIII-related protein
M Furlan, BA Perret, EA Beck
Biochimica et Biophysica Acta (BBA) - Protein Structure 1979
Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor
JM Sodetz, JC Paulson, PA McKee
The Journal of biological chemistry 1979
Blut und Blutkrankheiten
L Heilmeyer, K Betke, KG von Boroviczény, D Busch, E Grundmann, H Heimpel, G Hoffmann, W Hunstein, W Keiderling, M Matthes, H Merker, W Müller, P Pfannenstiel
1968
The Plasma Proteins
ML Petermann
The Plasma Proteins 1960

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts